Ku Elaine, McCulloch Charles E, Roll Garrett R, Adey Deborah, Sood Puneet, Posselt Andrew, Grimes Barbara A, Johansen Kirsten L
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA; Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA.
Am J Transplant. 2025 Jun;25(6):1274-1278. doi: 10.1016/j.ajt.2025.01.014. Epub 2025 Jan 22.
Bariatric surgery has been shown to be safe in chronic kidney disease and improves access of patients to transplantation. Whether bariatric surgery after kidney transplantation is associated with improved graft or patient survival has not been examined nationally. We included adults with obesity who received a first kidney transplant according to the US Renal Data System between 2003-2019. We matched 4 controls to each case of bariatric surgery based on age at transplantation, sex, donor type, diabetes, and body mass index at transplantation. We examined the association between bariatric surgery and graft failure or death using multivariable Cox proportional hazards models and Fine-Gray models accounting for death as a competing risk. We included 770 patients, of whom 155 (20%) received bariatric surgery. Median age was 45 years and 56% were women. Receipt of bariatric surgery was associated with improved graft survival (hazard ratio [HR], 0.57; 95% CI, 0.34-0.98) in fully adjusted models, although findings did not consistently maintain statistical significance in competing risk analyses (subHR, 0.60; 95% CI, 0.35-1.02). Receipt of bariatric surgery was associated with lower risk of death (HR, 0.45; 95% CI, 0.26-0.76). In conclusion, bariatric surgery is associated with improved patient survival and potentially graft survival after kidney transplantation.
减重手术已被证明在慢性肾病患者中是安全的,并且能提高患者接受移植手术的几率。在全国范围内,尚未对肾移植后进行减重手术是否能改善移植物或患者的生存率进行研究。我们纳入了2003年至2019年间根据美国肾脏数据系统接受首次肾移植的肥胖成年人。我们根据移植时的年龄、性别、供体类型、糖尿病情况以及移植时的体重指数,为每例接受减重手术的患者匹配4名对照。我们使用多变量Cox比例风险模型和将死亡作为竞争风险因素的Fine-Gray模型,研究了减重手术与移植物衰竭或死亡之间的关联。我们共纳入770例患者,其中155例(20%)接受了减重手术。患者的中位年龄为45岁,女性占56%。在完全调整的模型中,接受减重手术与移植物存活率提高相关(风险比[HR],0.57;95%置信区间[CI],0.34 - 0.98),尽管在竞争风险分析中这一结果并非始终保持统计学显著性(亚风险比,0.60;95% CI,0.35 - 1.02)。接受减重手术与死亡风险降低相关(HR,0.45;95% CI,0.26 - 0.76)。总之,减重手术与肾移植后患者生存率提高以及潜在的移植物生存率提高相关。